| Market Cap | ₹10,847Cr |
| ROE | 41.49% |
| P/E Ratio(TTM) | 80.69 |
| EPS(TTM) | 8.16 |
| P/B Ratio | 10.38 |
| Dividend Yield | 0.00% |
| Industry P/E | 32.98 |
| Book Value | 63.41 |
| Debt to Equity | 0.88 |
| Face Value | 1 |
| Parent Organisation | Rubicon Research |
| NSE Symbol | RUBICON |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 59.37 | ||
| Ajanta Pharma | NA (0.00%) | 32.53 | ||
| Gland Pharma | NA (0.00%) | 37.40 | ||
| Eris Lifesciences | NA (0.00%) | 49.04 |